Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

Presentation TCT 2024

TCT 425: Impact of Coronary Lesion Complexity on 5-Year Outcomes After Bioresorbable Polymer Sirolimus-Eluting Stent Implantation: Insights From the e-ULTIMASTER Registry

Presenter: Shoichi Kuramitsu

October 29, 2024

Presentation TCT 2023

TCT 79: Impact of sex on clinical outcomes in patients undergoing complex percutaneous coronary angioplasty ((from the e-ULTIMASTER Study).

Presenter: Gemina Doolub

October 26, 2023

Presentation TCT 2017

PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results

Presenter: Ioannis Iakovou, Gert Richardt, Shigeru Saito

October 30, 2017

Presentation TCT 2016

Stent Design and Comprehensive Data Review: From Nobori to Ultimaster Biolimus-Eluting Stents

Presenter: Dean J. Kereiakes, Pieter C. Smits, Shigeru Saito

October 30, 2016

Presentation TCT 2014

Clinical Outcomes of Patients With High Risk Acute Coronary Syndrome Treated With a New Generation Drug-Eluting Stent, Ultimaster compared with Xience ? Results from CENTURY II___

Presenter: Kazushige Kadota

September 16, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms VI: Ultimaster

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Shigeru Saito

September 15, 2014

Presentation TCT 2013

Ultimaster: Sirolimus Elution from a Novel Bioabsorbable Polymer

Presenter: Shigeru Saito

October 27, 2013

Advertisement

TCT 425: Impact of Coronary Lesion Complexity on 5-Year Outcomes After Bioresorbable Polymer Sirolimus-Eluting Stent Implantation: Insights From the e-ULTIMASTER Registry

TCT 79: Impact of sex on clinical outcomes in patients undergoing complex percutaneous coronary angioplasty ((from the e-ULTIMASTER Study).

PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results

Stent Design and Comprehensive Data Review: From Nobori to Ultimaster Biolimus-Eluting Stents

Clinical Outcomes of Patients With High Risk Acute Coronary Syndrome Treated With a New Generation Drug-Eluting Stent, Ultimaster compared with Xience ? Results from CENTURY II___

Cobalt-Chromium Sirolimus-Eluting Platforms VI: Ultimaster

Ultimaster: Sirolimus Elution from a Novel Bioabsorbable Polymer

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content